Plassche Douglas 4
4 · ELITE PHARMACEUTICALS INC /NV/ · Filed Jun 26, 2023
Insider Transaction Report
Form 4
Plassche Douglas
EVP Operations
Transactions
- Award
Options
2023-01-03$0.03/sh+7,500,000$225,000→ 7,500,000 totalExercise: $0.03From: 2024-01-03Exp: 2033-01-03→ Common Stock (7,500,000 underlying)
Footnotes (2)
- [F1]Options were awarded by the Board of Directions as part of Mr. Plassche's employment retention agreement.
- [F2]The options will best over a three-year period, commencing one year from the date of issuance. The first third will vest on January 3, 2024.